高强度聚焦超声与再次子宫肌瘤剔除术治疗复发性症状性子宫肌瘤的对比:回顾性研究
两组随访时间相当(56 vs 60个月,P=0.88)。HIFU组再干预累积风险在1年和3年低于再次肌瘤剔除术(0% vs 4.8%,3.2% vs 11.9%),但5年和8年无显著差异;HIFU组不良事件更少(59.4% vs 77%,P=0.01)。
要点
- HIFU消融与再次肌瘤剔除术的长期症状缓解相当。
- HIFU组再干预时间间隔更长,1年和3年再干预风险更低。
- HIFU组不良事件发生率显著低于再次肌瘤剔除术组。
核心结论
- HIFU消融治疗复发性症状性子宫肌瘤的长期症状缓解与再次肌瘤剔除术相当,且再干预时间间隔更长、不良事件更少。
主要发现
- 两组随访时间相当(56 vs 60个月,P=0.88)。
- HIFU组再干预时间间隔长于再次肌瘤剔除术组。
- HIFU组1年和3年再干预累积风险低于再次肌瘤剔除术组(0% vs 4.8%,3.2% vs 11.9%),但5年和8年无显著差异。
- HIFU组不良事件发生率低于再次肌瘤剔除术组(59.4% vs 77%,P=0.01)。
临床怎么用
- 对于子宫肌瘤剔除术后复发的症状性肌瘤患者,HIFU消融可作为再次手术的替代选择,尤其希望延迟再干预且降低并发症风险者。
局限性
- 回顾性研究设计,可能存在选择偏倚。
- 单中心研究,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare the long-term symptom alleviation and re-intervention of high-intensity focused ultrasound (HIFU) ablation and secondary myomectomy for women with recurrent symptomatic uterine fibroids following myomectomy. DESIGN: A retrospective analysis. SETTING: A general hospital in China. POPULATION: One hundred and eighty-eight women with recurrent symptomatic uterine fibroids following myomectomy. METHODS: Women who underwent HIFU ablation (n = 101) and secondary myomectomy (n = 87) at Chinese PLA General Hospital from January 2008 to December 2016 were analysed. Symptom relief and recurrence were evaluated using the transformed symptom severity scale (tSSS). The additional intervention and treatment-related complications were also recorded and compared. MAIN OUTCOME MEASURES: Difference in symptom alleviation, recurrence, re-intervention and complications. RESULTS: Follow-up time was comparable for the two groups (56 versus 60 months; P = 0.88). Regarding tSSS, at 3 months there was improvement in all tSSS for both treatment groups. The time to re-intervention was shorter in the myomectomy group. The cumulative risk for re-intervention after HIFU ablation at 1 and 3 years was lower than that after secondary myomectomy (0% versus 4.8%, 3.2% versus 11.9%, respectively); however, no significant difference was observed at 5 and 8 years. There were fewer adverse events in the HIFU ablation group than the myomectomy group (59.4% versus 77%, P = 0.01). CONCLUSIONS: High-intensity focused ultrasound ablation of recurrent symptomatic uterine fibroids offers comparable long-term alleviation of symptoms with longer time interval to re-intervention and fewer adverse events compared with secondary myomectomy. TWEETABLE ABSTRACT: High-intensity focused ultrasound ablation of recurrent uterine fibroids offered a longer time interval to re-intervention and fewer adverse events compared with myomectomy.
引用
- Liu X, Tang J, Luo Y, et al. Comparison of high-intensity focused ultrasound ablation and secondary myomectomy for recurrent symptomatic uterine fibroids following myomectomy: a retrospective study. BJOG. 2020. PMID: 32285586. doi:10.1111/1471-0528.16262
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。